Respiratory Health Supplements Market Accelerates as Consumers Prioritize Lung Wellness

Respiratory Health Supplements Market Size, Company Landscape with Market Value Chain

The global respiratory health supplements market size is calculated at US$ 8.78 in 2025, grew to US$ 9.46 billion in 2026, and is projected to reach around US$ 18.52 billion by 2035. The market is expanding at a CAGR of 7.75% between 2026 and 2035.

The respiratory health supplements market is expanding significantly due to rising chronic respiratory disease prevalence, increased awareness of respiratory health, and an increased emphasis on preventive healthcare. In the wake of recent global health crises that have highlighted the significance of respiratory wellness, consumers worldwide are increasingly turning to dietary supplements to boost immunity and lung function.

Key Takeaways

• The respiratory health supplements market will likely exceed USD 8.78 billion by 2025.
• Valuation is projected to hit USD 18.52 billion by 2035.
• Estimated to grow at a CAGR of 7.75% starting from 2026 to 2035.
• Asia Pacific dominated the respiratory health supplements market in 2024.
• North America is expected to grow at the fastest CAGR during the forecast period.
• By product type, the vitamins & minerals segment dominated the market share in 2024.
• By product type, the herbal supplements segment is expected to grow at the fastest CAGR during the forecast period.
• By formulation, the tablets & capsules segment dominated the market in 2024.
• By formulation, the gummies segment is expected to grow at the fastest CAGR during the forecast period.
• By consumer group, the adults segment dominated the market in 2024.
• By consumer group, the children segment is expected to grow at the fastest CAGR during the forecast period.
• By distribution channel, the brick-and-mortar segment dominated the respiratory health supplements market in 2024.
• By distribution channel, the e-commerce segment is expected to grow at the fastest CAGR during the forecast period.

Executive Summary Table

What are Respiratory Health Supplements?

Products with vitamins, minerals, herbs, and other dietary components that support lung function and general respiratory health are known as respiratory health supplements. They frequently do this by lowering inflammation and enhancing immunity. The respiratory health supplements market is fueled by rising respiratory disease prevalence, consumer awareness of preventive healthcare, and the need for natural, immunity-boosting supplements in a variety of convenient forms.

Respiratory Health Supplements Market Outlook

• Industry Growth Overview: The market is expected to grow significantly due to the demand for natural, immunity-boosting ingredients, growing respiratory disorders, and increased consumer awareness of preventive healthcare. Convenient gummies and integrated technology are examples of product innovation that further accelerate this growth.
• Major Investors: Amway Corporation, Herbalife Nutrition, Haleon plc, Glanbia plc, The Bountiful Company, Vitabiotics Ltd., NOW Foods, and Nature's Bounty are some of the leading investors and businesses in the respiratory health supplement market. These companies are important participants.
• Startup Ecosystem: The demand for natural, immunity-boosting products and the integration of digital health are driving the rapid growth of the startup ecosystem in the respiratory health supplements market. Resbiotic, a startup that provides probiotic supplements for respiratory support, is one example.

How is AI Transforming the Respiratory Health Supplements Market?

AI makes it possible to create more intelligent formulations, data-driven suggestions, and adaptive supplement protocols that are customized to each person's biology as consumer demand moves toward proactive and personalized healthcare. AI tools are revolutionizing the speed and precision of innovation in the wellness sector, from real-time nutrient deficiency prediction to biomarker and microbiome data analysis.

Segmental Insights

Product Type Insights

How Vitamins & Minerals Dominated the Market in 2024?

The vitamins & minerals segment was dominant in the respiratory health supplements market in 2024. The idea that vitamins C, D, and E, carotenoids, and omega-3 fatty acids may prevent the development of chronic respiratory disorders is currently being supported by a growing body of research. Many vitamins, minerals, and antioxidants have drawn a lot of attention lately for their potential to lessen the negative effects of smoking and environmental pollution.

Herbal Supplements

The herbal supplements segment is estimated to grow at the highest rate in the upcoming timeframe. Herbal products and plant extracts have been widely used in Indian Ayurveda and Traditional Chinese Medicine (TCM). These herbal remedies are crucial in the current medical era for boosting immunity and prolonging life. Herbal medicine has a long history of being used to treat respiratory disorders, hemorrhoids, bronchitis, chronic vascular problems, dysentery, and inflammation.

Probiotics

The probiotics segment is expected to grow significantly in the respiratory health supplements market during the forecast period. Probiotics are the good bacteria that support the host's immune system while preserving a balanced microbial population in the gastrointestinal tract. These probiotics have been used to treat a variety of respiratory tract infections (RTIs), such as cough, pharyngitis, laryngitis, pneumonia, and asthma, and their role in controlling immune function has been acknowledged.

Formulation Insights

Which Formulation Dominated the Market in 2024?

Tablets & Capsules

The tablets & capsules segment was dominant in the respiratory health supplements market in 2024. The most accessible dosage forms across all categories are capsules and tablets, and manufacturers of dietary supplements generally favor capsules. Because they give manufacturers formulation flexibility, capsules and tablets dominate the market. Because capsules come in a variety of sizes, manufacturers have a wide range of dosage options.

Gummies

The gummies segment is estimated to grow at the highest rate in the upcoming timeframe. Gummy candies are a great matrix for adding functional ingredients because they are so popular with people of all ages. Manufacturers can provide consumers with a delicious snack that has additional health benefits by incorporating plant extracts, vitamins, minerals, and other ingredients into their gummy candies.

Liquids

The liquids segment is expected to grow significantly in the respiratory health supplements market during the forecast period. The production of liquid supplements is a painstaking procedure intended to guarantee the uniform dispersion of ingredients in every bottle, thereby maximizing their nutritional potential. Because liquid supplements are easy to consume and absorb quickly, they have many advantages over traditional supplement forms.

Consumer Group Insights

How did the Adults Segment Dominate the Market in 2024?

The adults segment was dominant in the respiratory health supplements market in 2024.

Adults dominate the market due to several factors, such as rising disposable income, growing awareness among adults, and an increase in occupational respiratory disorders. Furthermore, as adults tend towards old age, the chances of getting respiratory disorders increase, due to which a lot of adults start consuming supplements as a preventive measure.

Children

The children segment is estimated to grow at the highest rate in the upcoming timeframe. Children with respiratory tract infections (RTIs) have a significant health care burden that includes both the direct medical care costs and the costs associated with parental absences from work. In order to strengthen children's immunity and prevent RTIs, supplements like probiotics and vitamins are strongly advised.

Geriatric

The geriatric segment is growing significantly in the respiratory health supplements market during the forecast period. Due to oxidative stress, age-related immune function decline, and the increased prevalence of chronic lung conditions, older adults may require respiratory supplements. Important supplements can help maintain lung health, lower inflammation, and lessen the risk and severity of infections when combined with a diet high in nutrients.

Distribution Channel Insights

Which Distribution Channel Dominated the Market in 2024?

Brick-and-mortar

The brick-and-mortar segment was dominant in the respiratory health supplements market in 2024. When navigating the vast array of supplement options available, customers prefer to shop in physical stores where they can ask knowledgeable employees for advice. Because consumers can directly assess product quality through labeling and packaging, in-store experiences offer a sense of trust and dependability that online shopping might not.

E-Commerce

The e-commerce segment is estimated to grow at the highest rate in the upcoming timeframe. The e-commerce market for supplements is changing at an unprecedented rate. In 2025, new regulations, AI-powered shopping, and changing consumer behavior will all have an impact on how brands sell and establish credibility online.

Regional Insights

What are the Key Trends in the Asia Pacific Market?

Asia Pacific dominated the respiratory health supplements market in 2024. The integration of traditional medicine and growing concerns about pollution are driving the widespread adoption of respiratory supplements across the Asia Pacific, especially in China and India. Proactive health management strategies that maximize effectiveness and reduce the need for medical intervention are enabled by trends in technology integration, such as direct-to-consumer distribution models, personalized supplements, and synergistic ingredient combinations with improved bioavailability.

China's Respiratory Illnesses Surge, Boosting Supplement Awareness

Interest in hMPV cases in China has increased recently, with reports of overcrowded hospitals. According to data released by China up to December 29, 2024, there has been a rise in acute respiratory infections in recent weeks, along with increased detection of seasonal influenza, rhinovirus, RSV, and hMPV, especially in northern provinces. Consumer knowledge of respiratory health supplements to strengthen immunity and treat respiratory illnesses has therefore increased.

Regulatory Support is Driving the Market in North America

North America is estimated to host the fastest-growing respiratory health supplements market during the forecast period. High consumer awareness, a robust presence of top supplement manufacturers, and a well-established healthcare infrastructure all contribute to the region's dominance. The area also gains from advantageous regulatory frameworks that promote product innovation and guarantee consumer safety.

Air Pollution: A Major Concern in the U.S.

In the U.S., air pollution has become a significant contributor to rising medical expenses, respiratory illnesses, and financial hardship. As a result, Americans are concentrating on taking health supplements. In the U.S., there are an estimated 23 million asthmatics and over 16 million COPD sufferers, many of whom are impacted by air pollution. Over $150 billion is spent on illnesses linked to air pollution. The average cost of treating an asthma attack is $1,000. For example, the average hospitalization cost for COPD is $8,000.

The Rising Consumer Awareness is Driving the Market in Europe

Europe is expected to grow at a significant CAGR in the respiratory health supplements market during the forecast period.     Growing consumer awareness of health and wellness, along with a shift toward preventive healthcare, are driving the region's expansion. The European Food Safety Authority's (EFSA) strict regulations guarantee product quality and safety, boosting consumer confidence and propelling market expansion.

UK Respiratory Supplements Market Expands

The UK market for respiratory health supplements is growing, fueled by heightened health awareness and environmental concerns. This expansion, highlighted by rising consumer demand for immune and breathing support products, presents strong growth opportunities for the industry in the coming years.

South America's Lung Boost: Chronic Illness Drives Supplement Need

South America is expected to grow significantly in the respiratory health supplements market during the forecast period. The market is driven by a high regional disease burden. In Brazil, approximately 20 million individuals are affected by asthma, pushing consumers toward preventative supplements. Severe acute respiratory infections in the state of Rio Grande do Sul alone resulted in 2,103 deaths during a recent twelve-month period. 

Brazil's Breathe-Easy Boom: Hospital Stays and Undiagnosed Cases

Respiratory diseases are a major health crisis, accounting for over $1 billion in annual healthcare costs for the Brazilian government. An estimated 15.8% of adults over forty have undiagnosed COPD. This high incidence of unmanaged conditions fuels demand for accessible, over-the-counter supplements.

Middle East & Africa's Vitality Push: Pollution and Vitamin Deficiency

The Middle East and Africa are expected to grow at a lucrative CAGR in the respiratory health supplements market during the forecast period. Market growth is linked to environmental factors and nutrient gaps. Air pollution in urban areas contributes to respiratory ailments. Furthermore, studies indicate an up to 13% increase in acute infections in specific groups with higher than recommended doses of certain vitamins.

Gulf Nations' Gold Standard: High Costs and System Fragmentation

The GCC region's healthcare spending as a percentage of GDP varies, with the UAE at approximately 3.5% and Saudi Arabia at 5.7%. The challenge is a healthcare system marked by fragmentation and high costs, which impacts access to specialized care, driving consumer reliance on preventative wellness and supplements.

Respiratory Health Supplements Market Value Chain Analysis

Research & Development (R&D)

R&D focuses on finding and verifying active ingredients, such as vitamins, probiotics, or herbal extracts, that can successfully support respiratory health as demonstrated by scientific research and clinical trials.

Key Companies: Johnson & Johnson, Roche, Pfizer, Novartis, Merck & Co., AstraZeneca, and Eli Lilly.

Formulation & Final Dosage Preparation

To deliver the active ingredients effectively and ensure optimal bioavailability for targeted action in the respiratory system, this stage involves developing stable, effective dosage forms (such as capsules, syrups, and powders).

Key Companies: Sun Pharmaceutical Industries, Cipla, Dr. Reddy's Laboratories, Lupin, Aurobindo Pharma, Abbott India, and Glenmark Pharmaceuticals.

Patient Support & Services

To increase patient compliance and satisfaction and ensure the supplements are used appropriately and effectively, value is added through educational materials, clear usage instructions, and support programs.

Key Companies: Roche, Pfizer, Novartis, Sanofi, Lupin, Dr. Reddy's Laboratories, and Mylan.

Company Landscape

1. Company: Haleon plc

Company Overview:

• Haleon is a leading global consumer health company dedicated to delivering better everyday health.
• Its vast portfolio includes world-class brands across five major categories, including VMS (Vitamins, Minerals, and Supplements) and Respiratory health.

Corporate Information:

• Headquarters: Weybridge, United Kingdom
• Year Founded: 2022 (as a standalone company following demerger from GSK)
• Ownership Type: Public (LSE: HLN, NYSE: HLN)

History and Background:

• Haleon was formed in July 2022 following the demerger of the Consumer Healthcare division of GlaxoSmithKline (GSK).
• The company was built upon the joint venture between GSK's consumer brands and Pfizer's consumer health business, positioning it as a pure-play consumer health leader.

Key Milestones/Timeline:

• 2024: Completed the sale of its non-US Nicotine Replacement Therapy business for approximately £458 million.
• March 2025: Pfizer sold its remaining stake in Haleon for approximately £2.5 billion, completing its full exit.

Business Overview:

• Haleon operates globally, managing a portfolio of market leading brands such as Otrivin, Theraflu, and Centrum.
• The company aims to improve access to better health for over 1.2 billion people and drives growth through scientific innovation.

Business Segments/Divisions:

• Primary Segments: Oral Health, Pain Relief, VMS (Vitamins, Minerals, and Supplements), Respiratory, and Digestive Health.

Geographic Presence: 

• Key Markets: North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA).
• Products are available in over 100 countries.

Key Offerings: 

• Respiratory: Otrivin (nasal sprays), Robitussin (cough relief), Theraflu (cold and flu).
• VMS (Supplements): Centrum (multivitamins) and Caltrate, which include critical immunity boosters like Vitamin C and Zinc.

End-Use Industries Served:

• Focus: Consumer Health, Over-The-Counter (OTC) drugs, and Dietary Supplements.

Key Developments and Strategic Initiatives:

• Mergers & Acquisitions: No major respiratory supplement M&A since the spin-off, focusing on organic growth and optimizing the portfolio.
• Product Launches/Innovations: 2024 saw the launch of the Otrivin Nasal Mist with innovative dispensing technology, gaining share in every market launch.
• Distribution channel strategy: Multi-channel, with e-commerce accounting for approximately 12% of net revenue in 2024.

Technological Capabilities/R&D Focus:

• Innovation Focus Areas: Utilizing scientific substantiation and behavioral science to develop new VMS and Respiratory products, with a focus on natural and plant-based ingredients.

Competitive Positioning:

• Strengths & Differentiators: Strong portfolio of trusted, category-leading brands; significant scientific heritage derived from GSK and Pfizer.
• Market presence & ecosystem role: Global leader in consumer health with high influence in VMS and OTC Respiratory segments.

SWOT Analysis:

• Strength: Strong global brand equity, deep R&D heritage.
• Weakness: Pressure from private label brands, high operational costs.
• Opportunity: Growth in emerging markets, increasing consumer focus on self-care and immunity.
• Threat: Intense competition in supplements, regulatory changes.

Recent News and Updates:

• Press Releases: Mid-2025 results highlighted resilience in VMS and Respiratory, driven by new product formulations and successful price realization.
• Industry Recognitions/Awards: Received recognition for its digital transformation efforts and brand advertising in 2024.

2. Company: Amway Corporation

Company Overview:

• Amway is the world's largest direct-selling company, specializing in nutrition, beauty, and home care. 
• Its Nutrilite brand is a global leader in the Vitamins, Minerals, and Supplements (VMS) market, which includes key respiratory support products.

Corporate Information:

• Headquarters: Ada, Michigan, USA
• Year Founded: 1959
• Ownership Type: Private (Owned by the DeVos and Van Andel families)

History and Background:

• Amway was founded by Jay Van Andel and Richard DeVos, establishing the direct-selling model.
• The acquisition of the Nutrilite brand in 1972 was foundational to its dominance in the nutritional supplement space, driven by its seed-to-supplement philosophy.

Key Milestones/Timeline:

• 1972: Acquired Nutrilite, becoming a leader in VMS.
• 2024: Continued strategic investments in its organic Nutrilite farms and digital platforms for IBOs.

Business Overview:

• Amway operates through a vast network of Independent Business Owners (IBOs).
• The company generates annual revenue of over $8 billion, with nutrition being the largest category.

Business Segments/Divisions:

• Primary Segments: Nutrilite (Nutrition/VMS), Artistry (Beauty), and Home.
• The Nutrilite division provides the core respiratory and immunity supplements.

Geographic Presence:

• Key Markets: Asia (particularly China and India), North America, and Europe.
• Operates in over 100 countries and territories.

Key Offerings:

• Respiratory/Immunity: Nutrilite Triple Protect (Vitamin C, Turmeric, Licorice), Nutrilite Vasaka, Mulethi & Surasa (Traditional Herbs Range), and immunity-focused Vitamin C products.
• The Traditional Herbs Range is specifically formulated to support respiratory health with expectorant and anti-inflammatory benefits.

End-Use Industries Served:

• Focus: Dietary Supplements, Skincare, Home Care.

Key Developments and Strategic Initiatives:

• Product Launches/Innovations: June 2025 saw the launch of Nutrilite Triple Protect in key markets like India, a plant-based supplement offering triple-action benefits for immunity, gut, and anti-inflammatory support. 
• Capacity Expansions/Investments: Continuous investment in organic farms ensures a traceable, high-quality ingredient source for Nutrilite supplements.
• Distribution channel strategy: Primarily Direct Selling via IBOs, complemented by a strong digital and e-commerce presence for order fulfillment and business support.

Technological Capabilities/R&D Focus:

• R&D Infrastructure: Operates the Nutrilite Health Institute and global R&D facilities with a focus on ingredient traceability.
• Innovation Focus Areas: Personalized Nutrition (tailored supplement recommendations), microbiome health, and leveraging Ayurvedic wisdom for new herbal formulations like the Vasaka, Mulethi & Surasa blend.

Competitive Positioning:

• Strengths & Differentiators: Unique direct-selling model fosters exceptional customer loyalty; vertical integration with certified organic farms ensures purity and quality.
• Market presence & ecosystem role: Dominant player in the global VMS category, especially in high-growth Asian markets where herbal supplements are highly valued.

SWOT Analysis:

• Strength: Unrivaled direct-selling reach, farm-to-supplement quality control.
• Weakness: High reliance on the IBO network, brand perception challenges in some markets.
• Opportunity: Rapid growth in Asia, increasing demand for organic and traceable health products.
• Threat: Intense competition from e-commerce brands, regulatory scrutiny in the direct sales sector.

Recent News and Updates:

• Press Releases: Q4 2024 announced significant initiatives to accelerate digital transformation, including AI tools for IBOs to enhance customer engagement and product education.
• Industry Recognitions/Awards: Continuously recognized as the World's No. 1 Selling Vitamins & Dietary Supplements Brand.

Top Vendors' Offerings in the Respiratory Health Supplements Market

Top Companies in the Respiratory Health Supplements Market

• Amway Corporation
• Herbalife Nutrition Ltd.
• Glanbia PLC
• Haleon plc (brands include Otrivin, Theraflu, etc.)
• Nu Skin Enterprises, Inc.
• Nature's Sunshine Products, Inc.
• The Bountiful Company
• Vitabiotics Ltd.
• NOW Foods
• Nature's Bounty
• Unijules Life Sciences Ltd.
• Pristine Organics Pvt. Ltd.
• Zoic Pharmaceuticals
• Nutra Healthcare Pvt. Ltd.
• Lifegenix
• Gummies India
• BeastLife
• MuscleBlaze
• GNC India
• Optimum Nutrition (ON)

Recent Developments in the Respiratory Health Supplements Market

• In November 2025, during the illness-prone cold season, LifeBridge developed a natural dietary supplement to boost lung immunity. Known as a "smart lung vitamin," IQ Air combines functional ingredients like cordyceps mushroom extract with vitamins like vitamin D3.
• In July 2025, Dr. Reddy's Laboratories announced the launch of CeleHealth Kidz Immuno Plus Gummies in India, marking its entry into the child nutrition market. According to the pharmaceutical company, the product's goal is to meet India's child immunity-related nutritional needs.

Segments Covered in the Report

By Product Type

• Vitamins & Minerals
• Herbal Supplements
• Omega-3 Fatty Acids
• Probiotics
• Others

By Formulation

• Tablets & Capsules
• Powder
• Liquids
• Gummies
• Others

By Consumer Group

• Adults
• Children
• Geriatric

By Distribution Channel

• Brick and Mortar 
  • Direct Selling
  • Chemists/Pharmacies
  • Health Food Shops
  • Hypermarkets
  • Supermarkets
• E-Commerce

By Region

• North America 
  • U.S.
  • Canada
  • Mexico
  • Rest of North America
• South America   
  • Brazil
  • Argentina
  • Rest of South America
• Europe  
  • Western Europe   
    • Germany
    • Italy
    • France
    • Netherlands
    • Spain
    • Portugal
    • Belgium
    • Ireland
    • UK
    • Iceland
    • Switzerland
    • Poland
    • Rest of Western Europe
  • Eastern Europe   
    • Austria
    • Russia & Belarus
    • Türkiye
    • Albania
    • Rest of Eastern Europe
• Asia Pacific   
  • China
  • Taiwan
  • India
  • Japan
  • Australia and New Zealand,
  • ASEAN Countries (Singapore, Malaysia)
  • South Korea
  • Rest of APAC
• MEA   
  • GCC Countries  
    • Saudi Arabia
    • United Arab Emirates (UAE)
    • Qatar
    • Kuwait
    • Oman
    • Bahrain
  • South Africa
  • Egypt
  • Rest of MEA